Table 5.

Agreement between Hypothetical Treatment Responses and Observed Practice

	Hypothetical	Observed	Agreement	OR (95% CI)
	Statin Use Rate
Diabetes (n=1496)	1263 (84.4%)	1021 (68.3%)	63.6%	1.20 (0.90, 1.61)
High risk/high LDL-C (n=457)	432 (94.5%)	175 (38.3%)	38.5%	0.65 (0.29, 1.47)
Low risk/high LDL-C (n=344)	137 (39.8%)	172 (50.0%)	52.0%	1.19 (0.77, 1.83)
	Addition of Non-Statin Lipid-Lowering Treatment
High LDL-C despite adherence to high intensity statin	159 (55.2%)	62 (21.5%)	44.1%	0.70 (0.40, 1.24)

^*Non-statin lipid-lowering treatment included addition of ezetimibe in 11 patients, fibrate, fish oil or bile acid sequestrant in 57 patients

Agreement = % of patients treated the way clinician said they would treat in the corresponding hypothetical scenario.

OR = odds ratio for likelihood of treatment when comparing clinicians who reported likely vs. less likely to treat in hypothetical scenarios

CI = confidence interval; OR = odds ratio; All other abbreviations can be found in Table 1.